These results confirmed the validity of D-bLP-mediated TSM-remolding on enhancing second M-bLP extravasation from tumor vasculature into the distal matrix, thereby holding great potential to facilitating their accessibility to cancer cells. The gene discussed is DYNLRB1; the disease is cancer.